Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Allergy|September 2, 2005
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN networkL Heinzerling, A J Frew, C Bindslev-Jensen, et al.
Allergy|February 28, 2007
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways documentN G Papadopoulos, P Xepapadaki, P Mallia, et al.
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.
Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|December 1, 1991
Ultrastructural effects of PCMS on mycelial-yeast transition in Histoplasma capsulatumG Borgia, A Tallarino, J Crowell, et al.
European Review for Medical and Pharmacological Sciences|October 5, 2020
Impact of COVID-19 pandemic on otolaryngology, ophthalmology and dental clinical activity and future perspectivesM Ralli, F Candelori, F Cambria, et al.
Translational Medicine @ Unisa|February 13, 2015
Heart Failure in a Dedicated Outpatient Clinic: Results after 58 Month Follow-Up. Can it be Enough?M Mirra, G Vitulano, N Virtuoso, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 24, 1998
Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertensionA Lambiase, M Centofanti, A Micera, et al.
Minerva Medica|April 1, 1990
[The clinical, histological and ultrastructural findings in a case of acute steatosis of pregnancy with a severe cholestatic syndrome]M Visconti, P G Rabitti, G Uomo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancerM Venturini, L Del Mastro, O Garrone, et al.
Pageof 22